Founders’ Edge is a syndicate of several active Finnish angels with expertise in areas such as medtech, analytics, B2B SaaS, machine learning and NLP.
Product type: Pharma
Bocap invests into growth stage Finnish SMEs, typically between startup venture capitalists and buyout funds. They seek profitable high growth companies with a turnover of €4M or more. Many of their portfolio companies are either driving or heavily using digitalization.
They invest up to €10M per company directly from the fund and their partners can invest a similar amount as well.
They’re a minority investor, seeking an ownership stake of between 10-49%.
Investiere is a Swiss fund that does VC investments and syndicates those with their network of Swiss HNIs, institutions etc. They have invested over €120M already.
They have a preference for B2B companies, but are interested in checking B2G and strong B2C cases as well.
They’re happy to do lead/solo/follow investments in Switzerland and mostly do follow investments outside Switzerland.
CapMan Growth seeks companies with an already fast-growing revenue and whose goal is to double their revenue in the near future. They’re largely agnostic towards sectors and business types, focusing on the evidence of the company’s ability to grow.
They seek growth companies doing approx. €1M or more in recurring revenue (e.g. SaaS) or considerably more of non-recurring revenue.
They prefer to invest €5-10M tickets. In addition to direct investment, they are happy to bring their partner companies on board to larger investment rounds of up to approx. €20M.
They’re always a minority investor, often the lead (in Finland prefer to lead). They prefer to actively assist in growing the companies through a board seat and other ways.
Angelus Funding is a group of 45 international angel investors. They’re investing across the globe without any sector limitations. They seek startups that have traction with a clear path to revenue. They invest also in non-startups.
Contacts to Stephan Reckie, sreckie@angelusfunding.com.
E2MC Ventures invests into space startups in Europe and globally. E2MC = Europe to Mars Capital. They’re looking for any and all kinds of space-related startups, including e.g. clinical trials or production in space.
Beiersdorf is a corporation focusing on skin care solutions, managing brands like Nivea and looking for companies that will help shape the future of skin care and wellbeing.
They’re interested in being the first pilot client of a startup, whether the offering is related software or a physical product.
Tehnopol Startup Incubator is located in Tallinn, Estonia. Applications are open all through the year, selection process and intake are in batches around the year.
Current focus areas are health tech, space tech, B2B ICT, greentech and smart cities. Startups from other areas are also welcome.
Most of their participating companies are B2B or B2C. They also have a separate program focused on the needs of B2G startups, which they’re happy to tell more about.
Participating teams have to have or establish a company in Estonia (takes 15 minutes) within a month of joining the program.
Generalist co-investment fund from Lithuania. They invest alongside three or more angels or VC funds that are not backed by public money. They consider all business sectors, however the fund wouldn’t invest into weapons or vices (cigarettes, gambling etc.).
They can fund up to 70% of a total investment round. They cap their return at 6% annually during the investment period, with the excess shared among other investors of the syndicate. The investments must benefit Lithuania, e.g. companies need to have or open an office and hire employees in Lithuania.
Access 4 Future is a market entry program for startups wishing to help people in the target countries get better access to healthcare: India, Niger, Philippines, Egypt, Thailand.
The program’s support includes connections locally (piloting), regionally and globally (scalability) and covers startups’ piloting costs. Each location has a different challenge for startups to help in, and they have different application periods during autumn 2020. Challenges include for example furthering the education and training of doctors.
The chosen solutions have to be scaleable. For example a solution that will be piloted in two hospitals might later expand to the state, then the country and finally internationally.